Potential bias of preoperative intravitreal anti-VEGF injection for complications of proliferative diabetic retinopathy.

<h4>Purpose</h4>Intravitreal anti-VEGF injection (IVI) is administered before vitrectomy to assist management of proliferative diabetic retinopathy (PDR)-related complications. In the clinical setting, retinal surgeons determine the use of preoperative IVI based on individual criteria. I...

Full description

Saved in:
Bibliographic Details
Main Authors: Kei Takayama, Hideaki Someya, Hiroshi Yokoyama, Takeshi Kimura, Yoshihiro Takamura, Masakazu Morioka, Hiroto Terasaki, Tetsuo Ueda, Nahoko Ogata, Shigehiko Kitano, Maki Tashiro, Taiji Sakamoto, Masaru Takeuchi
Format: article
Language:EN
Published: Public Library of Science (PLoS) 2021
Subjects:
R
Q
Online Access:https://doaj.org/article/eb6c180c79794c898f39cfa4ae99e127
Tags: Add Tag
No Tags, Be the first to tag this record!